PACS Group Dividends and Buybacks
Dividend criteria checks 0/6
PACS Group does not have a record of paying a dividend.
Key information
0%
Dividend yield
0.3%
Buyback Yield
| Total Shareholder Yield | 0.3% |
| Future Dividend Yield | 0% |
| Dividend Growth | -10.0% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | 0% |
Recent dividend and buyback updates
Recent updates
PACS: Q1 Execution And 2026 Outlook Will Drive Repricing Potential
Analysts have raised their average price target on PACS Group from about $35 to roughly $49.67, citing updated models following the company's recent Q1 results and refreshed 2026 guidance, along with what they describe as a strong quarter that has helped the stock regain traction with the Street. Analyst Commentary Recent research updates on PACS Group focus heavily on how the latest Q1 results and refreshed 2026 guidance feed into valuation, execution risk, and the stock's growth profile.PACS Group, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
PACS Group, Inc. ( NYSE:PACS ) investors will be delighted, with the company turning in some strong numbers with its...PACS Group: Strong Comeback That's Backed By Improving Fundamentals
Summary PACS Group is reaffirmed as a 'Buy' for long-term investors, following a 257% rebound from oversold lows. PACS demonstrates robust credit health with $795M liquidity, 0.1x net leverage, and strong interest coverage, supporting aggressive organic and acquisition-driven growth. Guidance for FY26 includes 8% revenue growth and 22% adjusted EBITDA growth, with margin expansion driven by facility maturation and industry consolidation opportunities. Despite a recent rally, PACS trades at a forward EV/EBITDA of 12.4 versus its peer NHC at 17.2, making it attractive on corrections. Read the full article on Seeking AlphaPACS Group: Under The Radar Healthcare Stock To Buy On Corrections
Summary PACS Group is a hidden gem stock with strong growth potential in the skilled nursing and assisted living facility industry. The company has shown aggressive growth through acquisitions, and as SNF facilities mature, growth is likely to remain healthy. Despite limited analyst coverage, PACS stock has shown an uptrend and is expected to outperform index and healthcare sector returns in the next three to five years. Read the full article on Seeking AlphaPACS Group: A Healthy Debut For This Acute Care Provider
Summary PACS Group shares rose 10% on the first day of trading after its IPO. The company operates 208 facilities across 9 states, providing post-acute care to 20,000 patients on a daily basis. Concerns about leverage, earnings power, and risks such as reimbursement policies and competition make investors cautious. Read the full article on Seeking AlphaStability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if PACS's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if PACS's dividend payments have been increasing.
Dividend Yield vs Market
| PACS Group Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (PACS) | 0% |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.1% |
| Industry Average (Healthcare) | 1.9% |
| Analyst forecast (PACS) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate PACS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate PACS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: PACS is not paying a notable dividend for the US market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as PACS has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/29 15:47 |
| End of Day Share Price | 2026/06/29 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PACS Group, Inc. is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jason Cassorla | Citigroup Inc |
| Lisa Gill | J.P. Morgan |
| Calvin Sternick | J.P. Morgan |